Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Raw Materials (2023)

Neuroone Medical Technologies (NMTC) has disclosed Raw Materials for 1 consecutive years, with $1.0 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Raw Materials changed N/A year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Dec 2023, changed N/A, and an annual FY2023 reading of $1.2 million, changed N/A over the prior year.
  • Raw Materials was $1.0 million for Q4 2023 at Neuroone Medical Technologies, down from $1.2 million in the prior quarter.
  • Across five years, Raw Materials topped out at $1.2 million in Q3 2023 and bottomed at $1.0 million in Q4 2023.